Comparison of Estimated Performance Rates for Breast Cancer Diagnosed in 2008
The performance rates below have been computed based on data directly reported from RPCI’s Cancer Registry, and are compared to national benchmarks. Once again, the care of RPCI patients who did not receive treatment was carefully reviewed. Most notable is the second table showing chemotherapy in hormone receptor negative cancer. These cases were nonconcordant for two reasons: a few patients decided not to undergo chemotherapy because of personal and medical reasons; and a number received treatment, but just a few days outside the 120 day time window stipulated in the measure.
The estimated performance rates for the groups compare the proportion of women under age 70 who received adjuvant radiation therapy within one year of breast-conserving surgery.